David Rosmarin, MD
Chair, Department of Dermatology
Associate Professor of Dermatology
Kampen-Norins Scholar in Dermatology
- Phone
- (317) 274-7705
- Address
-
EH 139
DERM
IN
Indianapolis, IN - PubMed:
Bio
Dr. Rosmarin is the Chair of the Department of Dermatology at Indiana University and a clinical investigator. He previously served as Vice-Chair for Research and Education at Tufts Medical Center focusing on clinical trials for inflammatory disorders of the skin. For his training, Dr. Rosmarin went to medical school at NYU, dermatology residency at Boston University-Tufts Combined training program, and fellowship at Brigham and Women's Hospital. Dr. Rosmarin's studies have resulted in him becoming the PI for multicentered trials evaluating topical ruxolitinib in vitiligo, which has led to the first ever FDA indication for repigmenting vitiligo. Dr. Rosmarin is the first to use dupilumab for bullous pemphigoid which is now in a phase 3 program for an indication. Clinically Dr. Rosmarin is nationally recognized and serves as a referral for physicians with difficult-to-manage inflammatory diseases such as atopic dermatitis. Dr. Rosmarin educates medical students, residents, and research fellows.
Key Publications
Year | Degree | Institution |
---|---|---|
2005 | MD | New York University |
2001 | MA | Harvard University |
2001 | BA | Harvard University |
Vitiligo
Atopic Dermatitis
Inflammatory diseases
Vitiligo
Atopic Dermatitis
Inflammatory diseases